Goldman Sachs analyst Alexander Blostein raised the firm’s price target on Carlyle to $50 from $46.25 and keeps a Buy rating on the shares. The firm says lower interest rates and “sluggish” deal recovery leave downside risks across most capital markets stocks into the Q3 reports. While prospects of faster rate cuts and stronger equity markets “have propelled the risk-on behavior” across many capital markets stocks, deal activity rates remain sluggish, which is a continued headwind for many alternative managers amid “very stretched” valuation multiples, organic growth for most traditional managers deteriorated in Q3, and lower interest rates present a “meaningful risk” to earnings for most brokers and wealth managers, the analyst tells investors in a research note. Goldman sees the exchanges and trust banks as “relative bright spots” into the Q3 results.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CG:
- StandardAero opens at $31.00, IPO priced at $24
- Carlyle announces strategic investment into North Bridge ESG
- Carlyle initiated with an Equal Weight at Wells Fargo
- ‘Private Markets Are the Hot Spot’: Analyst Suggests 2 Alternative Asset Stocks to Consider
- NFL owners vote to allow PE investment in franchises, Washington Post says